X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ASTRAZENECA PHARMA - Comparison Results

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ASTRAZENECA PHARMA DR. DATSONS LABS/
ASTRAZENECA PHARMA
 
P/E (TTM) x -10.9 118.7 - View Chart
P/BV x 0.2 16.9 1.0% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ASTRAZENECA PHARMA
Mar-14
DR. DATSONS LABS/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1261,285 9.8%   
Low Rs31634 4.9%   
Sales per share (Unadj.) Rs133.0189.6 70.1%  
Earnings per share (Unadj.) Rs0.2-0.2 -74.5%  
Cash flow per share (Unadj.) Rs6.63.8 171.9%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.868.6 187.6%  
Shares outstanding (eoy) m31.6625.00 126.6%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.65.1 11.6%   
Avg P/E ratio x516.1-4,712.7 -11.0%  
P/CF ratio (eoy) x11.8249.6 4.7%  
Price / Book Value ratio x0.614.0 4.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,47723,988 10.3%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m561,605 3.5%   
Avg. sales/employee Rs ThNM3,040.2-  
Avg. wages/employee Rs ThNM1,029.2-  
Avg. net profit/employee Rs ThNM-3.3-  
INCOME DATA
Net Sales Rs m4,2114,740 88.8%  
Other income Rs m7992 85.5%   
Total revenues Rs m4,2894,832 88.8%   
Gross profit Rs m569-130 -438.1%  
Depreciation Rs m204101 202.0%   
Interest Rs m4300-   
Profit before tax Rs m13-139 -9.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0139 0.0%   
Tax Rs m65 119.8%   
Profit after tax Rs m5-5 -94.3%  
Gross profit margin %13.5-2.7 -493.1%  
Effective tax rate %48.0-3.7 -1,310.7%   
Net profit margin %0.1-0.1 -106.2%  
BALANCE SHEET DATA
Current assets Rs m6,8522,726 251.3%   
Current liabilities Rs m6,7112,435 275.6%   
Net working cap to sales %3.36.1 54.5%  
Current ratio x1.01.1 91.2%  
Inventory Days Days16174 218.1%  
Debtors Days Days31841 781.3%  
Net fixed assets Rs m3,6731,035 354.8%   
Share capital Rs m31750 633.2%   
"Free" reserves Rs m3,761942 399.1%   
Net worth Rs m4,0781,716 237.6%   
Long term debt Rs m1,6710-   
Total assets Rs m12,6334,156 304.0%  
Interest coverage x1.0NM-  
Debt to equity ratio x0.40-  
Sales to assets ratio x0.31.1 29.2%   
Return on assets %3.4-0.1 -2,811.6%  
Return on equity %0.1-0.3 -39.7%  
Return on capital %7.70-  
Exports to sales %22.95.7 401.6%   
Imports to sales %14.36.5 221.2%   
Exports (fob) Rs m964270 356.8%   
Imports (cif) Rs m602306 196.5%   
Fx inflow Rs m964375 257.3%   
Fx outflow Rs m607470 129.1%   
Net fx Rs m357-96 -373.5%   
CASH FLOW
From Operations Rs m1,345-8 -16,602.5%  
From Investments Rs m-2,256-146 1,548.1%  
From Financial Activity Rs m-1,200862 -139.2%  
Net Cashflow Rs m-2,111709 -297.9%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 0.3 -  
FIIs % 1.4 15.7 8.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 9.1 1,034.1%  
Shareholders   20,807 12,856 161.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   GSK PHARMA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  IPCA LABS  ALKEM LABORATORIES  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Sensex Touching New Highs, Takeaways from Acquisition of HPCL and Top Stocks in Action Today(Pre-Open)

BSE Sensex is on a roll. The index touched a record high of 35,798 yesterday. Considering a span of one year, the benchmark index has delivered a 32% return.

Related Views on News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS